Nuvation Bio (NUVB) News Today → You won't believe what Citigroup just did to it's depositors (From American Alternative) (Ad) Free NUVB Stock Alerts $2.77 -0.14 (-4.81%) (As of 06/7/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Up 4.6%Nuvation Bio (NYSE:NUVB) Stock Price Up 4.6%June 4, 2024 | americanbankingnews.comNuvation Bio (NYSE:NUVB) Given "Buy" Rating at HC WainwrightJune 3, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Down 7.7%Nuvation Bio (NYSE:NUVB) Trading Down 7.7%June 3, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Nuvation Bio (NYSE:NUVB)HC Wainwright restated a "buy" rating and set a $8.00 target price on shares of Nuvation Bio in a report on Monday.June 2, 2024 | prnewswire.comInnovent Announces Taletrectinib(ROS1 Inhibitor)Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual MeetingJune 1, 2024 | prnewswire.comInnovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual MeetingJune 1, 2024 | businesswire.comNuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual MeetingMay 31, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Up 4.3%Nuvation Bio (NYSE:NUVB) Trading 4.3% HigherMay 29, 2024 | businesswire.comNuvation Bio to Present at the Jefferies Global Healthcare ConferenceMay 24, 2024 | marketbeat.comHC Wainwright Weighs in on Nuvation Bio Inc.'s Q2 2024 Earnings (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Free Report) - HC Wainwright boosted their Q2 2024 EPS estimates for Nuvation Bio in a report released on Wednesday, May 22nd. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($0.07) for the quarter, up from their prioMay 24, 2024 | marketbeat.comNuvation Bio's (NUVB) "Outperform" Rating Reaffirmed at WedbushWedbush reiterated an "outperform" rating and set a $5.00 target price on shares of Nuvation Bio in a research note on Friday.May 23, 2024 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) to Post Q2 2025 Earnings of ($0.10) Per Share, HC Wainwright ForecastsNuvation Bio Inc. (NYSE:NUVB - Free Report) - Stock analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for Nuvation Bio in a research report issued on Wednesday, May 22nd. HC Wainwright analyst R. Burns anticipates that the company will post earnings per share of ($0.10)May 22, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Rating Reiterated by HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $8.00 price objective on shares of Nuvation Bio in a research report on Wednesday.May 17, 2024 | marketbeat.comNuvation Bio Inc. (NYSE:NUVB) Forecasted to Earn Q2 2024 Earnings of ($0.06) Per ShareNuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush decreased their Q2 2024 EPS estimates for Nuvation Bio in a research note issued to investors on Tuesday, May 14th. Wedbush analyst D. Nierengarten now forecasts that the company will earn ($0.06) per share for the quartMay 15, 2024 | markets.businessinsider.comBuy Rating Justified by Nuvation Bio’s Promising Drug Prospects and Strong FinancialsMay 15, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 6.1% Higher Nuvation Bio (NYSE:NUVB) Shares Up 6.1%May 14, 2024 | msn.comNUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024May 14, 2024 | finance.yahoo.comNuvation Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 3, 2024 | investing.comNuvation Bio Inc (NUVB)April 29, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up to $2.68Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.68April 24, 2024 | businesswire.comNuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 19, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Stock Price Up 5%Nuvation Bio (NYSE:NUVB) Shares Up 5%April 17, 2024 | benzinga.comNuvation Bio Stock (NYSE:NUVB), Analyst Ratings, Price Targets, PredictionsApril 17, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Price Target Raised to $5.00 at Royal Bank of CanadaRoyal Bank of Canada boosted their target price on Nuvation Bio from $4.00 to $5.00 and gave the stock an "outperform" rating in a research report on Wednesday.April 17, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst UpgradeNuvation Bio (NYSE:NUVB) Shares Gap Up After Analyst UpgradeApril 13, 2024 | markets.businessinsider.comStrategic Acquisition Bolsters Nuvation Bio’s Growth Potential and Pipeline ProspectsApril 11, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading 3.9% Higher Nuvation Bio (NYSE:NUVB) Trading Up 3.9%April 10, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Trading Down 8.4%Nuvation Bio (NYSE:NUVB) Shares Down 8.4%April 10, 2024 | businesswire.comNuvation Bio Completes Acquisition of AnHeart TherapeuticsApril 6, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $1.12 Million Position in Nuvation Bio Inc. (NYSE:NUVB)Assenagon Asset Management S.A. raised its position in Nuvation Bio Inc. (NYSE:NUVB - Free Report) by 219.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 738,831 shares of the company's stock after purchasing an additional 507,452April 2, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Down 6.5% Nuvation Bio (NYSE:NUVB) Shares Down 6.5%March 31, 2024 | seekingalpha.comWeek In Review: AriBio Sells China Rights To Alzheimer's Candidate In $770M DealMarch 28, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Sees Unusually-High Trading Volume Following Analyst UpgradeNuvation Bio (NYSE:NUVB) Sees Large Volume Increase on Analyst UpgradeMarch 28, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) PT Raised to $8.00 at HC WainwrightHC Wainwright raised their price target on shares of Nuvation Bio from $5.00 to $8.00 and gave the stock a "buy" rating in a research note on Thursday.March 28, 2024 | marketbeat.comQ2 2024 EPS Estimates for Nuvation Bio Inc. Increased by Wedbush (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Investment analysts at Wedbush lifted their Q2 2024 earnings estimates for shares of Nuvation Bio in a report issued on Monday, March 25th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.05) for the quMarch 28, 2024 | businesswire.comNuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial OfficerMarch 27, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Up to $2.88Nuvation Bio (NYSE:NUVB) Shares Gap Up to $2.88March 27, 2024 | msn.comBTIG upgrades Nuvation to buy, cites AnHeart acquisitionMarch 27, 2024 | msn.comNuvation Bio continues to surge as more upgrades follow after AnHeart dealMarch 27, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Upgraded at Jefferies Financial GroupJefferies Financial Group raised shares of Nuvation Bio from a "hold" rating to a "buy" rating and boosted their target price for the stock from $1.40 to $10.00 in a research report on Wednesday.March 26, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Reaches New 12-Month High at $2.65Nuvation Bio (NYSE:NUVB) Sets New 1-Year High at $2.65March 26, 2024 | marketbeat.comBTIG Research Upgrades Nuvation Bio (NYSE:NUVB) to BuyBTIG Research raised shares of Nuvation Bio from a "neutral" rating to a "buy" rating and set a $5.00 price objective on the stock in a research report on Tuesday.March 25, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Gap Down to $2.31Nuvation Bio (NYSE:NUVB) Shares Gap Down to $2.31March 22, 2024 | marketbeat.comNuvation Bio (NYSE:NUVB) Shares Up 5.1%Nuvation Bio (NYSE:NUVB) Trading Up 5.1%March 20, 2024 | finance.yahoo.comNUVB Apr 2024 2.000 putMarch 16, 2024 | finance.yahoo.comNUVB Apr 2024 0.500 callMarch 15, 2024 | msn.comNuvation Bio begins subject dosing in Phase I/II solid tumour trialMarch 14, 2024 | businesswire.comNuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid TumorsMarch 14, 2024 | baystreet.caBiotech Sector Advances in Pancreatic Cancer ResearchMarch 11, 2024 | marketbeat.comNuvation Bio Inc. Expected to Earn Q1 2024 Earnings of ($0.09) Per Share (NYSE:NUVB)Nuvation Bio Inc. (NYSE:NUVB - Free Report) - Equities researchers at HC Wainwright boosted their Q1 2024 earnings per share (EPS) estimates for shares of Nuvation Bio in a report released on Thursday, March 7th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings o Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address You won't believe what Citigroup just did to it's depositors (Ad)The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"... CLICK HERE TO GET YOUR GUIDE NOW NUVB Media Mentions By Week NUVB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVB News Sentiment▼0.200.76▲Average Medical News Sentiment NUVB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVB Articles This Week▼51▲NUVB Articles Average Week Get Nuvation Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Geron News MorphoSys News Dyne Therapeutics News Agios Pharmaceuticals News MoonLake Immunotherapeutics News Avidity Biosciences News Structure Therapeutics News ACADIA Pharmaceuticals News TG Therapeutics News Rhythm Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NUVB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored